StockData
Airsculpt Technologies, Inc. logo

Airsculpt Technologies, Inc. (AIRS) stock

AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3083% below fair value
$0.74+0.04 (+5.53%)

Close on Nov 17, 2026Market cap $53.26MP/E –Yield –

Airsculpt Technologies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Airsculpt Technologies's operating cash flow for the twelve months ending Jun 30, 2026 was $1.28M, down 87.7% year over year. For fiscal 2025 it was $3.10M, down 72.7% from the year before. The highest annual figure on record is $26.63M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.10M-72.7%
FY2024Dec 31, 2024$11.35M-52.6%
FY2023Dec 31, 2023$23.96M-2.0%
FY2022Dec 31, 2022$24.45M-8.2%
FY2021Dec 31, 2021$26.63M+90.8%
FY2020Dec 31, 2020$13.96M+182.6%
FY2019Dec 31, 2019$4.94M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.24M-124.8%
Q1 FY2026Mar 31, 2026$5.27M+507.3%
Q4 FY2025Dec 31, 2025-$2.53M-193.3%
Q3 FY2025Sep 30, 2025-$225.00K-112.3%
Q2 FY2025Jun 30, 2025$4.98M+44.8%
Q1 FY2025Mar 31, 2025$868.00K-74.2%
Q4 FY2024Dec 31, 2024$2.71M-44.2%
Q3 FY2024Sep 30, 2024$1.83M+188.2%
Q2 FY2024Jun 30, 2024$3.44M-71.9%
Q1 FY2024Mar 31, 2024$3.37M-45.9%
Q4 FY2023Dec 31, 2023$4.87M-26.7%
Q3 FY2023Sep 30, 2023$635.00K+93.0%
Q2 FY2023Jun 30, 2023$12.24M+17.7%
Q1 FY2023Mar 31, 2023$6.22M-12.2%
Q4 FY2022Dec 31, 2022$6.64M–
Q3 FY2022Sep 30, 2022$329.00K-96.1%
Q2 FY2022Jun 30, 2022$10.40M-29.0%
Q1 FY2022Mar 31, 2022$7.08M-22.9%
Q4 FY2021Dec 31, 2021-$5.71M–
Q3 FY2021Sep 30, 2021$8.53M–
Q2 FY2021Jun 30, 2021$14.64M–
Q1 FY2021Mar 31, 2021$9.18M–

More Airsculpt Technologies figures

See a number that looks wrong?